Haeger&Carlsson are recruiting a Downstream Scientist to join Diamyd Medical’s Biologics Manufacturing facility in Umeå.
Diamyd Medical develops precision medicine therapies for Type 1 Diabetes. Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production. DIAGNODE-3, a confirmatory Phase III trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the US. A biomanufacturing facility is being set up in Umeå for the manufacture of recombinant GAD65, the active ingredient in the antigen-specific immunotherapy Diamyd®.
We are looking for an experienced Downstream scientist with deep subject matter expertise in eucaryotic cell culture to advance the downstream process. The ideal candidate will possess extensive experience with downstream and a strong background in optimizing protein purification. This role involves designing and executing experiments to enhance the biological manufacturing processes. You will be part of the process development department and report to Manufacturing Manager.
Key responsibilities:
Qualifications:
If you’re an expert in downstream, ready to drive innovation in biological manufacturing, this is the perfect opportunity to make a significant impact. Don’t miss the chance to apply and take your career to the next level!
Frågor besvaras av:
Anna Freese 076-174 7581, anna.f@haegercarlsson.com
Lena Sörskog 070-692 4570, lena@haegercarlsson.com
Välkommen att ansöka via haegercarlsson.com
Apply